Graduate studies at Western
Journal of Medicine and Philosophy 31 (5):465 – 482 (2006)
|Abstract||There are individuals, including children, dying needlessly in poverty-stricken third world countries. Many of these deaths could be prevented if pharmaceutical companies provided the drugs needed to save their lives. Some believe that because pharmaceutical companies have the power to save lives, and because they can do so with little effort, they have a special obligation. I argue that there is no distinction, with respect to obligations and responsibilities, between pharmaceutical companies and other types of companies. As a result, to hold pharmaceutical companies especially responsible for saving lives in third world countries is unjustified.|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Azam Golam (2008). Moral Obligation of Pharmaceutical Companies Towards HIV Victims in Developing Countries. The Dhaka University Studies 64 (1):197-212.
Richard T. de George (2005). Intellectual Property and Pharmaceutical Drugs. Business Ethics Quarterly 15 (4):549-575.
Denis Gordon Arnold (ed.) (2009). Ethics and the Business of Biomedicine. Cambridge University Press.
William Flanagan & Gail Whiteman (2005). “AIDS is Not a Business”. International Corporate Responsibility Series 2:375-391.
Eng Tuck Cheah, Wen Li Chan & Corinne Lin Lin Chieng (2007). The Corporate Social Responsibility of Pharmaceutical Product Recalls: An Empirical Examination of U.S. And U.K. Markets. [REVIEW] Journal of Business Ethics 76 (4):427 - 449.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. [REVIEW] Journal of Business Ethics 48 (3):279-290.
Włodzimierz Kubiak (2005). Medicine and Pharmacy — Facts and Myths About the Development of an Innovative Pharmaceutical Industry in Poland. Science and Engineering Ethics 11 (1):41-51.
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
Pepe Lee Chang (2006). Who's in the Business of Saving Lives? Journal of Medicine and Philosophy 31 (5):465-482.
Lawrence Masek (2000). The Doctrine of Double Effect, Deadly Drugs, and Business Ethics. Business Ethics Quarterly 10 (2):483-495.
Added to index2009-01-28
Total downloads12 ( #101,226 of 739,352 )
Recent downloads (6 months)1 ( #61,538 of 739,352 )
How can I increase my downloads?